Cheap smaller cap stocks that promise acceleration in fundamentals – BofA
Seeking Alpha News (Fri, 19-Dec 11:57 AM ET)
Analysts Conflicted on These Healthcare Names: Ibio (IBIO), Q32 Bio (QTTB) and Progyny (PGNY)
TipRanks (Thu, 18-Dec 8:10 AM ET)
Globe Newswire (Thu, 20-Nov 9:23 AM ET)
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
Globe Newswire (Thu, 13-Nov 12:33 PM ET)
Progyny, Inc. Announces Third Quarter 2025 Results
Globe Newswire (Thu, 6-Nov 4:01 PM ET)
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
Globe Newswire (Thu, 23-Oct 1:08 PM ET)
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
Globe Newswire (Wed, 22-Oct 9:28 AM ET)
Transcarent Experience Store Expansion: More Options for Women's Health
Business Wire (Tue, 21-Oct 9:30 AM ET)
Progyny CEO Named World Economic Forum Champion for Women's Health
Globe Newswire (Tue, 7-Oct 9:30 AM ET)
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Progyny trades on the NASDAQ stock market under the symbol PGNY.
As of December 23, 2025, PGNY stock price declined to $25.57 with 1,654,955 million shares trading.
PGNY has a beta of 0.32, meaning it tends to be less sensitive to market movements. PGNY has a correlation of 0.02 to the broad based SPY ETF.
PGNY has a market cap of $2.20 billion. This is considered a Mid Cap stock.
Last quarter Progyny reported $313 million in Revenue and $.45 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.16.
In the last 3 years, PGNY traded as high as $44.95 and as low as $13.39.
The top ETF exchange traded funds that PGNY belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
PGNY has outperformed the market in the last year with a price return of +78.3% while the SPY ETF gained +17.6%. PGNY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.5% and +3.5%, respectively, while the SPY returned +3.5% and +0.9%, respectively.
PGNY support price is $26.34 and resistance is $27.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY shares will trade within this expected range on the day.